Related Experiment Video
Updated: Dec 29, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Brainstem auditory pathway of children with acute lymphoid leukemia on chemotherapy with methotrexate
Renata Aparecida Leite1, Jéssica Sales Vosgrau1, Leticia Cortez Neto1
1Universidade de São Paulo, Faculdade de Medicina, Curso de Fonoaudiologia, São Paulo SP, Brazil.
Insights
Children undergoing chemotherapy for acute lymphoblastic leukemia (ALL) may experience auditory pathway damage in the brainstem. This hearing impairment, particularly in the lower brainstem, is linked to methotrexate treatment.
Area of Science:
- Neuroscience
- Pediatric Oncology
- Audiology
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Chemotherapy, including methotrexate, is a standard treatment for ALL.
- Chemotherapy can have ototoxic side effects, potentially affecting hearing.
Purpose of the Study:
- To investigate auditory pathway function in the brainstem of children with ALL receiving chemotherapy.
- To identify potential correlations between chemotherapy regimens and auditory pathway alterations.
Main Methods:
- Evaluation of 14 children (ages 2-12) diagnosed with ALL.
- Utilized audiological assessments including acoustic immitance, audiometry, otoacoustic emissions, and auditory brainstem response (ABR).
Main Results:
- 35.71% of children with normal hearing thresholds exhibited ABR alterations.
- Auditory impairment showed a predominance in the lower brainstem.
- 80% of affected children received intrathecal methotrexate within 30 days; 40% had high cumulative intravenous methotrexate doses.
Conclusions:
- Chemotherapy for ALL can lead to brainstem auditory pathway impairment in children.
- The lower brainstem appears particularly vulnerable.
- Intrathecal and cumulative intravenous methotrexate doses may be associated with these auditory changes.
Objective:
Investigate the auditory pathway in the brainstem of children with acute lymphoblastic leukemia submitted to chemotherapy (by intravenous or intrathecal infusion).
Methods:
Fourteen children aged between 2 and 12 years with diagnosis of acute lymphoid leukemia were evaluated. The following procedures were used: meatoscopy, acoustic immitance measurements, tonal audiometry, vocal audiometry, transient otoacoustic emissions, and auditory brainstem response.
Results:
From the 14 children with normal auditory thresholds, 35.71% showed an alteration in auditory brainstem response, with a predominance of hearing impairment in the lower brainstem. It was found that 80% of the children with alteration had used intrathecal methotrexate less than 30 days and that 40% had the highest cumulative intravenous methotrexate doses.
Conclusion:
Children with acute lymphoblastic leukemia submitted to chemotherapy, present auditory pathway impairment in the brainstem, with a predominance of a low brainstem.
Related Concept Videos
Auditory Pathway
When viewed cross-sectionally, the cochlea reveals the scala vestibuli and scala tympani flanking...
Anatomy of the Ear

